| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Cash flows from operating activities | | | | | | | | |
| Net income | 0.2 | 1.1 | 1.7 | 2.3 | 1.8 | 2.5 | 1.4 | 2.3 |
| |
| Adjustments to reconcile net income to net cash from operating activities: | | | | | | | | |
| Depreciation and amortization | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Amortization of intangibles | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Amortization of securities | 3.7 | 3.5 | 4.0 | 5.5 | 7.5 | 6.2 | 0.3 | 0.2 |
| Gain on sale of loans held for sale | -0.6 | -0.6 | | | -0.8 | -0.4 | | |
| Provision for credit losses | 0.5 | | | | 0.2 | | | |
| Decrease in interest receivable | -0.1 | -0.2 | -0.3 | -0.1 | -0.2 | -0.2 | -0.5 | -0.1 |
| Decrease (increase) in deferred taxes | 0.0 | 0.0 | -9.3 | 9.4 | -0.1 | -0.2 | 0.6 | 0.1 |
| (Decrease) increase in accrued expenses | 2.1 | -2.5 | 12.0 | -10.3 | 1.4 | -0.3 | 43.9 | -45.5 |
| Income from life insurance investment | -0.3 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 | -0.2 |
| (Gain) on life insurance investment | -0.4 | | | | | | | |
| Loss on the sale of investment securities | | | 108.1 | | 0.1 | | 179.7 | -87.7 |
| Net cash provided by operating activities | 4.4 | 0.0 | 10.6 | 10.5 | 8.6 | 10.3 | 1.4 | 7.7 |
| |
| Cash flows from investing activities | | | | | | | | |
| Proceeds from (investment in) the redemption of restricted stock, net | 1.0 | | | | -0.9 | | | |
| Investment in limited partnership | -0.1 | -0.1 | | | | | | |
| Proceeds from the sale of fixed assets | 0.1 | | | | 0.0 | | -0.1 | 0.2 |
| Net purchase of property and equipment | -4.6 | -0.7 | -0.9 | -0.3 | -0.5 | -1.9 | -0.1 | -0.2 |
| Net cash (used in) investing activities | -22.2 | -9.8 | -11.1 | -8.8 | -46.8 | -81.3 | -142.1 | -77.7 |
| |
| Cash flows from financing activities | | | | | | | | |
| Dividends paid in cash | -0.9 | -0.9 | -0.9 | -0.9 | -0.9 | -0.9 | -0.9 | -0.9 |
| Proceeds from issuance of common stock | 0.2 | | | | 0.2 | | | |
| Repayments of long-term debt | | | 15.0 | -5.0 | -10.0 | | 11.5 | -9.6 |
| Net cash provided by financing activities | 23.1 | 6.1 | 5.2 | 11.3 | 7.1 | 31.3 | 48.3 | 64.5 |
| Cash and cash equivalents, beginning of period | | 35.0 | | | | 88.1 | | |
| Cash and cash equivalents, end of period | 5.2 | 31.3 | 4.6 | 13.1 | 16.4 | 0.9 | -92.5 | -5.4 |
| |
| Supplemental Cash Flow information: | | | | | | | | |
| Cash paid for: Interest | 5.8 | 4.8 | 3.4 | 1.9 | 0.9 | 1.2 | 0.5 | 1.4 |
| Taxes | | 0.4 | | | | | | 0.5 |
| Supplemental non-cash disclosures: | | | | | | | | |
| Change in unrealized loss on securities available for sale | 0.1 | 3.4 | | | -21.6 | -18.0 | | |